loadpatents
name:-0.017879962921143
name:-0.011064052581787
name:-0.0071539878845215
Foricher; Yann Patent Filings

Foricher; Yann

Patent Applications and Registrations

Patent applications and USPTO patent grants for Foricher; Yann.The latest application filed is for "fused pentacyclic imidazole derivatives as modulators of tnf activity".

Company Profile
6.9.12
  • Foricher; Yann - Paris FR
  • Foricher; Yann - Riedisheim N/A FR
  • Foricher; Yann - Strasbourg FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
App 20210252012 - Brookings; Daniel Christopher ;   et al.
2021-08-19
Fused Pentacyclic Imidazole Derivatives
App 20210155637 - De Haro Garcia; Teresa ;   et al.
2021-05-27
Fused pentacyclic imidazole derivatives as modulators of TNF activity
Grant 10,980,814 - Brookings , et al. April 20, 2
2021-04-20
Fused pentacyclic imidazole derivatives
Grant 10,906,919 - De Haro Garcia , et al. February 2, 2
2021-02-02
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
App 20200046723 - Brookings; Daniel Christopher ;   et al.
2020-02-13
Fused Pentacyclic Imidazole Derivatives
App 20190367535 - De Haro Garcia; Teresa ;   et al.
2019-12-05
Fused pentacyclic imidazole derivatives
Grant 10,202,405 - De Haro Garcia , et al. Feb
2019-02-12
Fused Pentacyclic Imidazole Derivatives
App 20170305932 - De Haro Garcia; Teresa ;   et al.
2017-10-26
Pyrimidooxazocine derivatives as mTOR-inhibitors
Grant 9,120,812 - Braun , et al. September 1, 2
2015-09-01
Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics
Grant 9,102,628 - Foricher , et al. August 11, 2
2015-08-11
Pyrimidooxazocine Derivatives As Mtor - Inhibitors
App 20140378433 - Braun; Alain ;   et al.
2014-12-25
Process for the manufacture of chroman derivatives, especially .alpha.-tocopherol and alka-noates thereof
Grant 8,431,727 - Bonrath , et al. April 30, 2
2013-04-30
Process for the manufacture of trimethylhydroquinone dialkanoates
App 20110144358 - Bonrath; Werner ;   et al.
2011-06-16
Derivatives Of Pyrazole 3,5-carboxylates, Their Preparation And Their Application In Therapeutics
App 20100160377 - FORICHER; Yann ;   et al.
2010-06-24
Process for the manufacture of alkenylated hydroxylated aromatic compounds, of chroman compounds and of their acylated derivatives
Grant 7,696,364 - Bonrath , et al. April 13, 2
2010-04-13
Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alka-noates thereof
App 20090176998 - Bonrath; Werner ;   et al.
2009-07-09
Process for the manufacture of trimethylydroquine dialkanoates
App 20070049762 - Bonrath; Werner ;   et al.
2007-03-01
Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof
App 20050277777 - Bonrath, Werner ;   et al.
2005-12-15
Process for the manufacture of alkenylated hydroxylated aromatic compounds, of chroman compounds and of their acylated derivatives
App 20050171362 - Bonrath, Werner ;   et al.
2005-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed